Patent intelligence · US
US 6900027
Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays
Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays
Patent details — US 6900027
- Jurisdiction
- US
- Status
- expired
- Grant date
- May 31, 2005
- Expiration
- May 26, 2025
- Applicant
- Precision Therapeutics, Inc.
- Claims
- 8
- CPC classes
- A61P, A61P17/02, A61P31/00, A61P35/00
Quick answer
US 6900027 (Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays) is held by Precision Therapeutics, Inc.. Status: expired. Granted May 31, 2005. Expires May 26, 2025 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Precision Therapeutics, Inc.
- Grant date
- Expiration
- Claims
- 8
- CPC classes
- A61P, A61P17/02, A61P31/00, A61P35/00, A61P37/02
More from Precision Therapeutics, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12419920
Bifidobacterium longum NCIMB 41676
granted -
US 12410418
Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome
granted -
US 12351839
Rationally-designed single-chain meganucleases with non-palindromic recognition sequences
granted -
US 12344676
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
granted -
US 12336835
Neuromodulation to target glucose transporter and/or incretin pathways
granted -
US 12232492
Disinfection of bacteriophages products using supercritical carbon dioxide
granted -
US 12233135
Therapeutic constructs for treating cancer
granted -
US 12180463
Lactobacillus reuteri
granted
Frequently asked questions
What is US patent 6900027?
US 6900027 (Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays) is held by Precision Therapeutics, Inc.. Status: expired. Granted May 31, 2005. Expires May 26, 2025 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 6900027?
Precision Therapeutics, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 158 pharmaceutical patents for this assignee.
When does US 6900027 expire?
Our index shows an expiration date of May 26, 2025 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.